Our laboratory has a mouse tumour model composed of metastatic cell lines derived from a fi brosarcoma tumour clone that present a different MHC class I phenotype depending on the immune status of the host: MHC class I-negative in immunocompetent BALB/c mice and MHC class I-positive in nude mice. MHC class I-positive metastases are highly immunogenic and the tumours are fi nally rejected by the host.
MHC-F locus is a non-classical class I gene with a low polymorphism.The function of its products is yet unclear.In the present study,cDNA from MHC transcripts of ape species close to humans (i.e.:Pongidae) has been obtained and sequenced.It has been founl that orthologous sequences to HLA-F are present in bonobo (Pan paniscus) ,gorilla (Gorilla gorilla) and orangutan (Pongo pygmaeus).Transcripts have also been found in these ape lines. Protein theoretical products show that the "key residues" are conserved at the peptide binding region in these three ape species.The role of the MHC-F proteins in the immune responses remain to be solved and is discussed on the bases of its evolutionary conserved relative monomorphism and the comparison to HLA-G and -E putative effects on NK cells and cytolitic T lymphocites. To describe the diversity of KIR genes and in order to constitute our own panel, we studied 125 unrelated Caucasians from the South East of France. KIR typing was performed using PCR-SSP (kit Pel Freez) which identifi es the presence or absence of the following KIR genes : 2DL1, 2DL2, 2DL3, 2DL4, 2DL5, 2DS1, 2DS2, 2DS3, 2DS4, 2DS5, 3DL1, 3DL2, 3DL3, 3DS1, 2DP1, 3DP1, and the common variants of 2DL5, 2DS4 and 3DP1. We calculated gene frequency and determined genotype combinations. In our population, we identifi ed 44 different genotypes, 20 of which were unique, while the remaining genotypes were each observed from 2 to 19 times. The gene frequencies found in this population are concordant with previous studies. The numerous combinations found underline the diversity of KIR both in number and identity.
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STUDY OF A FRENCH CAUCASOID POPULATION: KIR GENES
Segregation analysis was done in seven Caucasian families accounting for 44 individuals and typing was performed by PCR-SSP. We determined 10 haplotypes previously described in the literature and deduced fi ve "new" haplotypes which are now under investigation. As described in the literature, we observed similar frequencies for groups A and B haplotypes in this Caucasian population.
THE IMPACT OF HLA-C AND KIR GENES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION.
Kursat Ozdilli*, Cigdem Kekik**, Fatma Oguz**, Yeliz Duvarci**, Hulya Bilgen**, Mahmut Carin**, Gunduz Gedikoglu*** *Halic University, Istanbul.**İstanbul Unıversity,Istanbul. ***Our-Leukemia Chidren Foundation, İstanbul Hematopoietic stem cell transplantation (HSCT) is the treatment of choice for a variety of hematological malignancies. Natural killer (NK) activity is controled by several NK-cell receptors including killer immunglobulin-like receptors (KIR) that interact with HLA-class I antigens. There would seem to be a little potential role for NK alloreactivity in HLA matched sibling donors where the donor's HLA type always includes the recipient's class I alleles. Recent studies have shown that NK cells maybe involved both in allogeneic bone marrow transplantation rejection and graft versus host disease (GvHD). In present study, we analysed the KIR genotypes and their ligands (HLA-C) in 20 allogeneic HLA-matched stem cell transplants to evaluate their impact on the outcome. A total of 20 leukemic patients (M/F:16/4, median age 14,3 years) and their HLA-A,-B,-DRB1 matched siblings were included in this study. PCR-SSP typing were used to detect HLA-C and KIR genes. Our results show HLA-C alleles were identic both in patients who underwent transplantation and donors. Group 2 HLA-C (C2) was found homozygot in 10, Group 1 HLA-C (C1) was found homozygot in 3 and C1+C2 were found in 7 patients out of 20. From 10 C2 homozygots, 7 patients survived and 3 of them died. From the 20 patients 8 (40%) of them experienced GvHD, 3 (15%) of them relapsed. Recipient KIR genotype was included in the donor genotype in 3 pairs of 20. Two of them experienced GvHD from the 3. The present study is rather signifi cant that it is the study which assessed the relation of the KIR in patients who underwent HSCT, for GvHD and survival. We believe studies like this will eventually help to understand the pathogenesis of GvHD and factors effecting survival after HSCT, but larger groups of studies must be done in future. KIRs genes are highly polymorphic, exhibiting extensive variation both in the number of genes per haplotype and allelic variation at each locus. KIRs exert either an activatory or an inhibitory effect upon cellular function following HLA ligand binding (importantly, KIRs and their ligands are not genetically linked). Inhibitory KIRs prevent NK cell mediated attack on normal cells, an effect modulated by the strong affi nity of inhibitory KIRs for HLA class I.
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THE ROLE OF KILLER-CELL IMMUNOGLOBULIN-LIKE
Recent studies have shown KIR polymorphisms to have a direct effect upon the outcome of haematopoietic stem cell transplantation, viral resistance, and in the development and progression of certain autoimmune disorders.
Method. This study investigated polymorphism of KIR genes and their HLA ligand expression in three related systemic autoimmune diseases, each with a common genetic association to HLA -A1, B8, DR3.
Seventy Primary Sjogren's syndrome (PSS), 320 Scleroderma (SSc), and 74 Systemic Lupus Erythematosus (SLE) patients were analysed for KIR genes and HLA ligand type using polymerase chain reaction sequence-specifi c primers (PCR-SSP). These patient groups were compared with a control panel of 223 healthy blood donors.
Results. The following differences between patient and control groups were observed. 1.In SSc a signifi cantly low frequency of KIR2DL1 (78% vs. 92%, p=0.05) 2. In PSS a signifi cantly high frequency of KIR2DS2 without KIR2DL2 (15.71% vs 4.9%, p=0.01). 3.No signifi cant differences were found in the SLE group.
Conclusion. This study shows that KIRs have a role in certain, but not all, systemic autoimmune diesease. These three diseases have overlapping clinical features as well as other common genetic features (preponderance of females, HLA-A1,B8,DR3). Despite this the KIR associations for these three diseases are clearly different.
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GENETIC DIVERSITY OF KIR NATURAL KILLER CELL MARKERS IN POPULATIONS FROM FRANCE, FINLAND, GUADELOUPE, SENEGAL AND REUNION
1Laure Denis, 2Jirki Sivula, 3Pierre-Antoine Gouraud, 1Nolwenn Kerdudou, 4Roger Chout, 5Corinne Ricard, 6Jean-Paul Moisan, 1Katia Gagne, 2Jukka Partanen and 1Jean-Denis Bignon 1EFS Nantes, 2Red Cross Helsinki, 3Inserm U558 Toulouse, 4Pointe-à-Pitre CHR, 5St Denis La Reunion CHR, 6CHU Nantes Many studies performed on mouse and human models showed that KIR receptors expressed on NK cells play an important role in Haematopoietic Stem Cell Transplantation (HSCT). A few groups are looking after the "Perfect mismatch" (Klas Karre) between KIR ligands (HLA molecules) and KIR receptors which would decrease reject and GvH (Graft-versusHost) reactions and improve survival. Moreover, due to their high polymorphism KIR markers could represent good tools in human genetic. In these contexts, the aim of this study was to study genetic diversity of KIR receptors in 5 different populations that may allow, with data concerning KIR receptors in HSCT, to select the "best" donor in term of HLA and KIR incompatibilities for a given recipient. With this end, using PCR-SSP, we evaluated KIR gene, genotypic and haplotypic frequencies, in fi ve selected populations from France (Fr), Guadeloupe (G), Senegal (S), Finland (Fi) and Reunion (R) to obtain neighbor-joining tree, illustrating distances between populations. The statistical analysis was performed by bootstrap method and Arlequin software. Through an important heterogeneity in KIR gene frequencies, results revealed the high diversity of G. and R., and the important specifi city of S.. The neighbor-joining tree obtained showed very close genetic distances between Fr., G. and R. and between Fr. and Fi.. Inversely, S. showed far genetic relations with the other countries, and interestingly an inverted ratio of KIR2DS4/1D alleles compared to caucasoids. These data precise the extended KIR diversity in the world and determine KIR genes as tools of interest in the human genetic. These should be taken into account in the HSCT donor selection if the role of KIR incompatibilities between donor and recipient is confi rmed. KIRs (Killer Cell Immunoglobulin like receptors) are exposed on NK cells. Aim of the study was to defi ne the genotypic and haplotypic structure of KIRs in the italian Caucasian population. The typing has been performed by a new PCR-SSP kit (Dynal Biotech, Pel-Freez) in a panel of 217 healthy unrelated volunteers in a multicentric evaluation of 22 laboratories.
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KIR GENOTYPING IN PATIENTS WITH MULTIPLE SCLEROSIS
The individual gene content varied from 7 to 15 without the pseudogene evaluation and from 7 to 17 including pseudoegenes. The frame work genes 2DL4, 3DL2, 3DL3 and the pseudogene 3DP1 are found in all individuals as already described in others studies. The gene 2DS4*003 was present in 89% of the population and 2DS4*001/*002 only in 33%. The transcribed allele 2DL5A*001 was recognized in 33% while the variant not transcribed *002-*004 in 28% of the population. Sixty-fi ve genotypes were identifi ed in the population; the most frequent are shown in the Only 4 (1.8%) genotypes with the profi le 2DL1-,2DL3-,2DL2+ were observed in the population. The remaining 22.5% genotypes are present only one or twice The frequencies of KIR genes detected in our study are comparable to other Caucasian populations, while some differences with non-caucasian population are observed. Natural killer cells (NK) interact with MHC-class I molecules on target cells. In humans, NK cells are negatively regulated by killer cell Ig-like receptors (KIR) recognizing groups of HLA class I alleles. KIR ligand mismatch in the graft versus host GVH direction is associated with improved survival in haploidentical, T-cell depleted hematopoetic stem cell transplantation (HSCT) for AML. The role for KIR-ligand mismatch in unrelated T-cell replete HSCT is more controversial. While some centers report benefi cial effects of KIR ligand mismatch on transplantation related mortality (TRM) and survival, data from our center could not confi rm such effects. In contrast, we observed increased infection related mortality and inferior survival for patients receiving KIR ligand mismatched grafts. Here we report an update of this analysis including totally 238 patients with hematological malignancies receiving grafts from an unrelated donor. Allele level typing was performed for all classical HLA loci. The selected patients were matched at allele level for HLA-A, -B and DRB1. KIR-ligand match/ mismatch (208/30) was predicted from the high resolution typing of HLA-C. KIR-ligand mismatch was associated with increased TRM (p<0.01) leading to a decreased overall survival (p=0.007). Relapse did not differ signifi cantly between the groups. The results were identical when only patients with myeloid malignancies were included in the analysis (n=155).
It seems clear that KIR ligand mismatching may not be used as a criteria for donor selection in unrelated HSCT at this stage. Further studies are warranted to defi ne the conditions that help to preserve/promote NK mediated graft-versus-leukemia effects. Such studies should focus on the role of KIR alleles (activating and inhibitory) as well as phenotypic assessment of the NK repertoire that mature in the recipient.
New Developments and Techniques
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THE
RELEVANT SIGNIFICANCE OF SOME WBC SUBPOPULATION RATIOS B Pantelis, 3rd IKA Hospital, Biopathology Department, Athens, GREECE The signifi cance of some ratios is obvious if we consider we usually report percentages of WBC subpopulations in the clinical fi eld. But what happens when we have to deal with individual ratios of subpopulations of WBCs? For example, the ratio of Band Forms to Lymphocytes was introduced by us as a means of describing the level of clinical acuity (Acuity Ratio) (AR) . Although this cannot be the case in every clinical situation, there are some instances where a lowering of lymphocytes coincides with a rise of stab cells at the beginning of an acute condition and later on, the decrease of band cells with the absolute increase of lymphocytes, especially the activated forms of them. This phenomenon creates a progressive diminution of AR. We speculated that this loss of acuity and the resulting transformation to chronicity cannot be described simply by a single percentage or a concentration of a certain subpopulation and, if this is true, why not try and other ratios and see what are their diagnostic or prognostic implications.
We examined a set of ratios between subpopulations: Stab cells to Neutrophils (SN), Stab cells to Lymphocytes, Stab cells to monocytes (SM), Neutrophils to Lymphocytes (NL). We present combined data from several different works, either comparing patients with fever (F) to non fever patients (NF), or groups of patients categorized by glycaemic levels -Noromoglycaemic (N), Hyperglycaemic (HG), Diabetic (DM)-or from a general sample of patients divided by clinical severity. Subpopulations were estimated by a combination of data of an hematology analyzer (SYSMEX) and differential counting. SN and AR differed signifi cantly between F diseases and NF acute diseases, these differences being unaffected by gender. When we discriminated for 3 degrees of clinical severity F patients differed signifi cantly in AR, SN and SM from NF patients only at medium severity (hospitalized patients) while at the minimum severity (outpatients) no change was established. At maximum severity (intensive care) the existing difference was not confi rmed statistically due to data paucity.
In NF patients the 3 glycaemic levels disturbed the SN while this was not the case in F patients. The SN of F patients was found three fold the value of NF patients at the normoglycaemic level and two fold at a medium hyperglycaemic level, while it was unaffected at maximum hyperglycaemic level (DM). The AR showed a similar pattern of differences between F and NF patients in different glycaemic levels although there was no such tremendous difference. A signifi cant escalation of AR was seen between glycaemic levels of NF patients, while in F patients the highest value was noticed in HG. Generally the glycaemic level differentiated the NL, SM, SN and AR in both sexes, considered separately, and between sexes of the same level signifi cant differences were established only in DM.
Although at the moment no clinical application can be established, these fi ndings suggest to us that separate subpopulation ratios are worth to be considered in research of biological laws with vast samples.
